Xarelto, once thought to be a safer alternative in blood thinners, has come under fire recently by doctors who are growing increasingly concerned about bleeding risks. Although all blood thinners pose a risk for bleeding, Xarelto lawsuits indicate that there is no known antidote for bleeding incidents with the newer class of drug as there is when bleeding occurs in patients who use warfarin.
Xarelto is a once-daily pill approved for use by the United States Food and Drug Administration in November 2011 to treat atrial fibrillation, a condition that causes blood to pool in the heart where it can clot and travel to the brain, causing strokes. When it was approved, researchers believed that Xarelto had a lower bleeding risk than warfarin and did not require the close monitoring required in patients taking warfarin. In addition, Xarelto did not require patients to make significant dietary and lifestyle changes necessary like they did with warfarin.
In March 2012, alarms were raised regarding the bleeding risks of Xarelto when an elderly Utah man died of a massive brain hemorrhage after a minor fall. In June 2014, the family of a Pennsylvania woman filed a Xarelto lawsuit after she died of an uncontrollable bleeding incident. More lawsuits have followed after patients suffered bleeding incidents that could not be controlled. Patients who take warfarin must have regular blood tests and avoid foods that are high in Vitamin K. When a patient taking warfarin suffers from bleeding, doctors administer a high dose of Vitamin K in order to stop the bleeding. In patients taking Xarelto, there is no known antidote, leading some patients to die when bleeding cannot be stopped.
Changes to Warnings
In January 2014, the FDA required the makers of Xarelto to add what is known as a Black Box Warning so that patients were clearly aware of the bleeding risk. In addition, the FDA required that a warning be added that there may not be an antidote for bleeding with the drug. However, when the warnings were added, Xarelto had been on the market for several years so that many patients had already suffered dangerous bleeding incidents, leading to Xarelto lawsuits.
If you or a loved one has suffered from a bleeding incident after taking Xarelto, or if a loved one has died from uncontrolled bleeding after taking the drug, you may be eligible for a product liability or wrongful death Xarelto lawsuit. Contact Carse Law today for a free, no obligation consultation to learn what rights you may have.